Evidence map›Paper›PMID 39803801›Full record

ArticleJournal of neuroimaging : official journal of the American Society of Neuroimaging

Poststroke Translocator Protein Expression Dynamics and Correlations to Chronic Infarction: A

Per Jensen, Brice Ozenne, Per Meden, Ling Feng, Gerda Thomsen, Lars Knudsen, Henrik Steglich-Arnholm, Kirsten Møller, Carsten Thomsen, Claus Svarer and 4 more

Abstract read
In one paragraph

Article in Journal of neuroimaging : official journal of the American Society of Neuroimaging. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Per JensenNeurobiology Research Unit, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0002-5246-390X
Brice OzenneNeurobiology Research Unit, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Per MedenDepartment of Neurology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.
Ling FengNeurobiology Research Unit, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Gerda ThomsenNeurobiology Research Unit, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Lars KnudsenNeurobiology Research Unit, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Henrik Steglich-ArnholmDepartment of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Kirsten MøllerDepartment of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Carsten ThomsenDepartment of Radiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Claus SvarerNeurobiology Research Unit, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Vincent BeliveauNeurobiology Research Unit, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Jens MikkelsenNeurobiology Research Unit, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Gitte KnudsenNeurobiology Research Unit, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Lars H PinborgNeurobiology Research Unit, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Funding

Danmarks Frie ForskningsfondDesirée and Niels Yde ́s foundationEuropean Union's seventh framework programme HEALTH-F2-2011-278850 (INMiND)The Research Committee of Rigshospitalet
6 · The paper itself

Abstract

background and purposeThis study aims to investigate the longitudinal changes in translocator protein (TSPO) following stroke in different brain regions and potential associations with chronic brain infarction.

methodsTwelve patients underwent SPECT using the TSPO tracer 6-Chloro-2-(4'-123I-Iodophenyl)-3-(N,N-Diethyl)-Imidazo[1,2-a]Pyridine-3-Acetamide, as well as structural MRI, at 10, 41, and 128 days (median) after ischemic infarction in the middle cerebral artery. TSPO expression was measured in lesional (MRI lesion and SPECT lesion), connected (pons and ipsilesional thalamus), and nonconnected (ipsilesional cerebellum and contralesional occipital cortex) regions. Correlations were explored between the volume of chronic infarction and TSPO expression in nonconnected regions of interest (ROIs) at 128 days

resultsThroughout the study period, TSPO levels decreased by 24%-33% in lesional ROIs, while levels increased in connected ROIs by 35%-69% and in nonconnected ROIs by 53%-77%. At 128 days poststroke, TSPO expression in ipsilesional cerebellum positively correlated with chronic infarction volume (p = 0.002, r

conclusionsThis study expands the current knowledge of spatial and temporal TSPO expression in humans by quantifying TSPO changes in lesional, connected, and nonconnected brain regions at three time points after cerebral infarction as well as correlating late-stage TSPO upregulation and chronic infarction volume.

Indexed as

BrainBrain InfarctionReceptors, GABAStrokeTomography, Emission-Computed, Single-PhotonAgedChronic DiseaseFemaleHumansIodine RadioisotopesMagnetic Resonance ImagingMaleMiddle AgedRadiopharmaceuticalsIodine RadioisotopesRadiopharmaceuticalsReceptors, GABATSPO protein, humanMRIneuroinflammationSPECTstroketranslocator protein

Identifiers

PMID39803801
PMCPMC11726615

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.